181 related articles for article (PubMed ID: 35860243)
1. ETV1 Positively Correlated With Immune Infiltration and Poor Clinical Prognosis in Colorectal Cancer.
Shen X; Zhou C; Feng H; Li J; Xia T; Cheng X; Zhao R; Zou D
Front Immunol; 2022; 13():939806. PubMed ID: 35860243
[TBL] [Abstract][Full Text] [Related]
2. Specific and redundant activities of ETV1 and ETV4 in prostate cancer aggressiveness revealed by co-overexpression cellular contexts.
Mesquita D; Barros-Silva JD; Santos J; Skotheim RI; Lothe RA; Paulo P; Teixeira MR
Oncotarget; 2015 Mar; 6(7):5217-36. PubMed ID: 25595908
[TBL] [Abstract][Full Text] [Related]
3. Tumor-Infiltrating Immune Cells Act as a Marker for Prognosis in Colorectal Cancer.
Ye L; Zhang T; Kang Z; Guo G; Sun Y; Lin K; Huang Q; Shi X; Ni Z; Ding N; Zhao KN; Chang W; Wang J; Lin F; Xue X
Front Immunol; 2019; 10():2368. PubMed ID: 31681276
[TBL] [Abstract][Full Text] [Related]
4. Capicua suppresses colorectal cancer progression via repression of ETV4 expression.
Lee JS; Kim E; Lee J; Kim D; Kim H; Kim CJ; Kim S; Jeong D; Lee Y
Cancer Cell Int; 2020; 20():42. PubMed ID: 32042269
[TBL] [Abstract][Full Text] [Related]
5. SEMA6B Overexpression Predicts Poor Prognosis and Correlates With the Tumor Immunosuppressive Microenvironment in Colorectal Cancer.
Li T; Yan Z; Wang W; Zhang R; Gan W; Lv S; Zeng Z; Hou Y; Yang M
Front Mol Biosci; 2021; 8():687319. PubMed ID: 34938771
[No Abstract] [Full Text] [Related]
6. ETS variant 5 promotes colorectal cancer angiogenesis by targeting platelet-derived growth factor BB.
Cheng X; Jin Z; Ji X; Shen X; Feng H; Morgenlander W; Ou B; Wu H; Gao H; Ye F; Zhang Y; Peng Y; Liang J; Jiang Y; Zhang T; Qiu W; Lu X; Zhao R
Int J Cancer; 2019 Jul; 145(1):179-191. PubMed ID: 30650178
[TBL] [Abstract][Full Text] [Related]
7. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
Front Immunol; 2019; 10():6. PubMed ID: 30761122
[No Abstract] [Full Text] [Related]
8. CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer.
Yue Y; Zhang Q; Sun Z
Front Immunol; 2021; 12():758040. PubMed ID: 35140706
[TBL] [Abstract][Full Text] [Related]
9. The Prognostic Significance of RIMKLB and Related Immune Infiltrates in Colorectal Cancers.
Cao Y; Deng S; Yan L; Gu J; Mao F; Xue Y; Qin L; Jiang Z; Cai W; Zheng C; Nie X; Liu H; Sun Z; Shang F; Tao K; Wang J; Wu K; Zhu B; Cai K
Front Genet; 2022; 13():818994. PubMed ID: 35444692
[TBL] [Abstract][Full Text] [Related]
10. Integrated Analysis of Expression and Prognostic Values of Acyl-CoA Dehydrogenase short-chain in Colorectal Cancer.
Wu Q; Yan T; Chen Y; Chang J; Jiang Y; Zhu D; Wei Y
Int J Med Sci; 2021; 18(16):3631-3643. PubMed ID: 34790035
[No Abstract] [Full Text] [Related]
11. ITGA5 is a prognostic biomarker and correlated with immune infiltration in gastrointestinal tumors.
Zhu H; Wang G; Zhu H; Xu A
BMC Cancer; 2021 Mar; 21(1):269. PubMed ID: 33711961
[TBL] [Abstract][Full Text] [Related]
12. The utility of ETV1, ETV4 and ETV5 RNA in-situ hybridization in the diagnosis of CIC-DUX sarcomas.
Smith SC; Palanisamy N; Martin E; Almenara J; McHugh JB; Choi EK; Lucas DR; Betz BL; Thomas D; Patel RM
Histopathology; 2017 Mar; 70(4):657-663. PubMed ID: 27790742
[TBL] [Abstract][Full Text] [Related]
13. The Prognostic Value of GNG7 in Colorectal Cancer and Its Relationship With Immune Infiltration.
Fang C; Zhong R; Qiu C; Zou BB
Front Genet; 2022; 13():833013. PubMed ID: 35281820
[No Abstract] [Full Text] [Related]
14. Function and regulation of the PEA3 subfamily of ETS transcription factors in cancer.
Qi T; Qu Q; Li G; Wang J; Zhu H; Yang Z; Sun Y; Lu Q; Qu J
Am J Cancer Res; 2020; 10(10):3083-3105. PubMed ID: 33163259
[TBL] [Abstract][Full Text] [Related]
15. The impact of SLC10A3 on prognosis and immune microenvironment in colorectal adenocarcinoma.
Wang B; Fan W; Tao Y; Zhang S; Wang J; Fan Z; Liu L; Wang Y
Eur J Med Res; 2024 Jan; 29(1):20. PubMed ID: 38178258
[TBL] [Abstract][Full Text] [Related]
16. Interferon regulatory factor family influences tumor immunity and prognosis of patients with colorectal cancer.
Chen YJ; Luo SN; Dong L; Liu TT; Shen XZ; Zhang NP; Liang L
J Transl Med; 2021 Sep; 19(1):379. PubMed ID: 34488791
[TBL] [Abstract][Full Text] [Related]
17. DCK is a promising prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma.
Song D; Wang Y; Zhu K; Tian L; Gao Q; Zhou J; Fan J; Wang X
World J Surg Oncol; 2020 Jul; 18(1):176. PubMed ID: 32690026
[TBL] [Abstract][Full Text] [Related]
18. Large tumor suppressor 2 is a prognostic biomarker and correlated with immune infiltrates in colorectal cancer.
Zhao C; Chen J; Liu Y; Ju S; Wang G; Wang X
Bioengineered; 2021 Dec; 12(2):11648-11661. PubMed ID: 34699318
[TBL] [Abstract][Full Text] [Related]
19. Identification of ANXA1 as a potential prognostic biomarker and correlating with immune infiltrates in colorectal cancer.
Liang Z; Li X
Autoimmunity; 2021 Mar; 54(2):76-87. PubMed ID: 33596760
[TBL] [Abstract][Full Text] [Related]
20. The prognosis analysis of
Huang W; Tian X; Guan X
Transl Cancer Res; 2020 Feb; 9(2):508-521. PubMed ID: 35117395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
